WCN26-2967 ORAL ADMINISTRATION OF ALLULOSE ATTENUATES CISPLATIN-INDUCED AKI VIA GLP-1 RELEASE

Read full text Summarise with VIRAT
Authors: Jumpei Yamashita, Wei Zou, Yusaku Iwasaki, Masaomi Nangaku, Shinji Tanaka
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

About 10% of hospitalized patients and 50% of intensive care unit patients suffer from acute kidney injury (AKI). Besides, it sometimes leads to chronic/end-stage kidney disease. But there is no specific treatment for AKI. Therefore, it is essential to find the new treatment strategy for AKI. Recently, several studies demonstrated that oral administration of D-allulose (rare sugar) induced glucagon-like peptide-1 (GLP-1) release to activate vagal afferent signaling and reduce food intake in mice.

Fields of Study & Subjects

Acute Kidney Injury Research Chemotherapy-induced organ toxicity mitigation Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103876–103876
Publication date
25 March 2026
Language
EN